| Literature DB >> 28955325 |
Peng Liu1, Dongyi Huang1, Xinwen Hu1, Yanqiong Tang1, Xiang Ma1, Rihui Yan1, Qian Han1, Jianchun Guo2, Yueling Zhang3, Qun Sun4, Zhu Liu1.
Abstract
Aeromonas veronii is an important pathogen of aquatic animals, wherein Small protein B (SmpB) is required for pathogenesis by functioning as both a component in stalled-ribosome rescue and a transcription factor in upregulation of virulence gene bvgS expression. Here a specific peptide aptamer PA-1 was selected from peptide aptamer library by bacterial two-hybrid system employing pBT-SmpB as bait. The binding affinity between SmpB and PA-1 was evaluated using enzyme-linked immunosorbent assay. The key amino acids of SmpB that interact with PA-1 were identified. After PA-1 was introduced into A. veronii, the engineered strain designated as A. veronii (pN-PA-1) was more sensitive and grew slower under salt stress in comparison with wild type, as the disruption of SmpB by PA-1 resulted in significant transcription reductions of virulence-related genes. Consistent with these observations, A. veronii (pN-PA-1) was severely attenuated in model organism zebrafish, and vaccination of zebrafish with A. veronii (pN-PA-1) induced a strong antibody response. The vaccinated zebrafish were well protected against subsequent lethal challenges with virulent parental strain. Collectively, we propose that targeting inhibition of SmpB by peptide aptamer PA-1 possesses the desired qualities for a live attenuated vaccine against pathogenic A. veronii.Entities:
Keywords: Aeromonas veronii; SmpB; bacterial two-hybrid system; live attenuated vaccines; selection of peptide aptamers library
Year: 2017 PMID: 28955325 PMCID: PMC5601406 DOI: 10.3389/fmicb.2017.01766
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Plasmids used in this study.
| Plasmids name | Description | Source or |
|---|---|---|
| Reference | ||
| pBT-LGF2 | Positive control, p15A ori, | Stratagene |
| pTRG-Gal11p | Positive control, ColE1 ori, | Stratagene |
| pBT | Bait plasmid, p15A ori, | Stratagene |
| pTRG | Prey plasmid, ColE1 ori, | Stratagene |
| pBT-SmpB | pBT derivative, expresses SmpB with λcI, CamR. | |
| pBT-SmpB ΔN34 | pBT-SmpB derivative, deletes 34-residue at N-terminal of SmpB. | |
| pBT-SmpB ΔN34C30 | pBT-SmpB derivative, deletes 34-residue at N-terminal and 30-residue at C-terminal of SmpB. | |
| pBT-SmpB ΔC30 | pBT-SmpB derivative, deletes 30-residue at C-terminal of SmpB. | |
| pBT (SmpB-G11S) | pBT-SmpB derivative, mutates G11S to AA. | |
| pBT (SmpB-T14I) | pBT-SmpB derivative, mutates T14I to AA. | |
| pBT (SmpB-F26I) | pBT-SmpB derivative, mutates F26I to AA. | |
| pBT (SmpB-E32AG) | pBT-SmpB derivative, mutates E32AG to AAA. | |
| pBT (SmpB-G133K) | pBT-SmpB derivative, mutates G133K to AA. | |
| pBT (SmpB-D138KR) | pBT-SmpB derivative, mutates D138KR to AAA. | |
| pBT (SmpB-K152) | pBT-SmpB derivative, mutates K152 to P. | |
| pTRG-SN | pTRG derivative, expresses SN with RNAP, TetR. | |
| pTRG-SN-peptides | pTRG derivative, expresses random peptide with RNAP, TetR. | |
| pTRG-PA-1 | pTRG derivative, expresses PA-1 with RNAP, TetR. | This study |
| pET-28a-SmpB | pET-28a derivative, expresses SmpB, KanR | This study |
| pET-28a-SN | pET-28a derivative, expresses SN, KanR. | This study |
| pET-28a-PA-1 | pET-28a derivative, expresses PA-1, KanR. | This study |
| pN-SN | pRE112 derivative, expresses SN under the control of pk18mobsacB NEOKAN promoter. | |
| pN-PA-1 | pRE112 derivative, expresses PA-1 under the control of pk18mobsacB NEOKAN promoter. | This study |
Bacterial strains used in this study.
| Strains name | Description | Source or |
|---|---|---|
| Reference | ||
| Wild type, ampicillin resistance, virulent to | ||
| The engineered | ||
| The engineered | ||
| The engineered | This study | |
| Δ | Stratagene | |
| Δ | Stratagene | |
| NEB | ||